Breast: Page 351

Breast MRI shows high negative predictive value in BI-RADS 3 lesions
By Kate Madden Yee
Monday, November 29 | 3:20 p.m.-3:30 p.m. | SSE01-03 | Room E450ABreast MRI exhibits a high negative predictive value in patients with BI-RADS category 3 lesions, according to a study from the Medical University of Graz in Graz, Austria, to be presented on Monday.
November 9, 2010
Targeted breast US identifies cancer BI-RADS 3 lesions found by MRI
By Kate Madden Yee
Monday, November 29 | 3:00 p.m.-3:10 p.m. | SSE01-01 | Room E450AUsing targeted ultrasound on breast lesions identified as BI-RADS category 3 by MRI can help identify malignancies, according to researchers from Brown University in Providence, RI.
November 9, 2010
PEM shows potential for breast cancer surgical planning
By Kate Madden Yee
Monday, November 29 | 11:40 a.m.-11:50 a.m. | VM21-15 | Arie Crown TheaterIn this scientific session, Johns Hopkins researchers will present study results suggesting that positron emission mammography (PEM) is a helpful tool for breast cancer surgical planning in early-stage breast cancer.
November 9, 2010
Positron emission mammography can be more specific than MRI
By Kate Madden Yee
Monday, November 29 | 9:25 a.m.-9:35 a.m. | VM21-06 | Arie Crown TheaterPositron emission mammography (PEM) is more specific than MRI for surgical management in women with ipsilateral breast cancer, according to researchers from Johns Hopkins at Green Spring Station in Lutherville, MD.
November 9, 2010
BSGI improves breast cancer detection -- but biopsies may still be needed
By Kate Madden Yee
Monday, November 29 | 9:05 a.m.-9:15 a.m. | VM21-04 | Arie Crown TheaterBreast-specific gamma imaging (BSGI) improves the detection of breast cancer, but the modality doesn't do away with the need for biopsy when indicated by mammography or ultrasound, according to researchers from Weinstein Imaging Associates in Pittsburgh.
November 9, 2010
MBI increases breast cancer detection in dense tissue
By Kate Madden Yee
Monday, November 29 | 8:55 a.m.-9:05 a.m. | VM21-03 | Arie Crown TheaterIn this paper presentation, researchers from the Mayo Clinic in Rochester, MN, will discuss how adding molecular breast imaging (MBI) to regular screening mammography for women with dense breasts increases cancer detection.
November 9, 2010
Preoperative breast MRI doesn't increase mastectomy rates
By Kate Madden Yee
Sunday, November 28 | 11:25 a.m.-11:35 a.m. | SSA01-05 | Arie Crown TheaterPreoperative MRI can be used in clinical practice for breast cancer staging without boosting mastectomy rates, according to researchers from the University of Milan School of Medicine.
November 9, 2010
Hologic posts mixed results for FY 2010
By AuntMinnie.com staff writers
Growth in service revenue and product sales propelled women's healthcare vendor Hologic to greater revenues in its fourth fiscal quarter and 2010 fiscal year.
November 8, 2010
Breast MRI shows high negative predictive value in BI-RADS 3 lesions
By Kate Madden Yee
Monday, November 29 | 3:20 p.m.-3:30 p.m. | SSE01-03 | Room E450ABreast MRI exhibits a high negative predictive value in patients with BI-RADS category 3 lesions, according to a study from the Medical University of Graz in Graz, Austria, to be presented on Monday.
November 8, 2010
Preoperative breast MRI doesn't increase mastectomy rates
By Kate Madden Yee
Sunday, November 28 | 11:25 a.m.-11:35 a.m. | SSA01-05 | Arie Crown TheaterPreoperative MRI can be used in clinical practice for breast cancer staging without boosting mastectomy rates, according to researchers from the University of Milan School of Medicine.
November 8, 2010
Dilon touts BSGI study results
By AuntMinnie.com staff writers
Breast-specific gamma imaging (BSGI) developer Dilon Diagnostics is touting the results of a study that found that the company's molecular breast imaging technology is accurate in establishing tumor size within 5 mm after neoadjuvant chemotherapy.
November 7, 2010
IsoRay receives QTDP grant
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical has been awarded $527,000 under the U.S. government's Qualifying Therapeutic Discovery Project (QTDP) program.
November 7, 2010
Previous Page
Page 351 of 578
Next Page